Changeflow GovPing Telecom & Technology Team ASSURE Wins Top Prize at NUS-SYNAPXE-IMDA ...
Routine Notice Added Final

Team ASSURE Wins Top Prize at NUS-SYNAPXE-IMDA AI Innovation Challenge 2026

Favicon for www.imda.gov.sg Singapore IMDA Press Releases
Published
Detected
Email

Summary

The NUS-SYNAPXE-IMDA AI Innovation Challenge 2026 concluded on 11 April 2026 with 880 students from 18 institutes forming 181 teams to develop AI-powered solutions for chronic conditions affecting approximately 1.8 million people in Singapore. Team ASSURE, comprising six students from the NUS Master of Science in Business Analytics programme, won the top prize of $10,000 for AssureCare Suite, a comprehensive AI-enabled home monitoring platform for elderly heart patients recovering between clinical visits.

Published by IMDA on imda.gov.sg . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The NUS-SYNAPXE-IMDA AI Innovation Challenge 2026 concluded with 880 students from 18 educational institutes competing to develop AI solutions for chronic conditions including diabetes, hypertension, and high lipid levels. Team ASSURE from the NUS Master of Science in Business Analytics programme won the top prize of $10,000 for AssureCare Suite, featuring AssureBot for voice-enabled daily check-ins and a Caregiver Portal for centralised patient monitoring.\n\nHealthcare providers, technology companies, and educational institutions may find these AI-powered healthcare solutions relevant for future development, though this announcement creates no immediate compliance obligations. The challenge encouraged students to use Singapore's MERaLiON and SEA-LION national multimodal large language models, reflecting Singapore's commitment to developing culturally sensitive AI for healthcare applications.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Be aware of scammers impersonating as IMDA officers or misrepresenting our policies. Government officials will NEVER call you to transfer money, verify refunds, disclose bank log-in details or request for your personal information. For scam-related advice, please call the ScamShield Helpline at 1799 or go to www.ScamShield.gov.sg.

  1. Architects of SG's Digital Future
  2. Resources
  3. Press Releases, Factsheets and Speeches
  4. Team ASSURE Clinches Top Prize at NUS–SYNAPXE–IMDA AI Innovation Challenge 2026 with Home Monitoring Platform for Cardiac Recovery

Team ASSURE Clinches Top Prize at NUS–SYNAPXE–IMDA AI Innovation Challenge 2026 with Home Monitoring Platform for Cardiac Recovery

22 APR 2026 | 4 mins read
SINGAPORE – 22 APR 2026

  1. The NUS–SYNAPXE–IMDA AI Innovation Challenge 2026 concluded on 11 April 2026 with AI-enabled solutions for cardiac patient monitoring, personalised health intervention for elderly adults and streamlined workflows for clinicians taking home the top prizes.

  2. Jointly organised by the National University of Singapore (NUS) Business Analytics Centre and various industry partners since 2014, the Challenge aims to drive innovation and create impactful solutions for communities. The 12 th annual edition of the competition welcomed 880 students from 18 institutes, including universities, polytechnics and junior colleges across Singapore, forming 181 teams to develop AI-powered solutions for chronic conditions such as diabetes, hypertension and high lipid levels, which affect about 1.8 million people in Singapore.

  3. Team ASSURE, comprising six students from the NUS Master of Science in Business Analytics programme, won the top prize of $10,000 for AssureCare Suite, a comprehensive AI-enabled home monitoring platform for elderly heart patients recovering between clinical visits. The platform features AssureBot, a voice-enabled AI companion that conducts daily check-ins, captures symptom updates and vital readings through natural speech, and provides medication and routine care reminders. This is complemented by a Caregiver Portal offering a centralised view of patient status, trend summaries, and escalation alerts.

Team ASSURE receiving their prize from Mr Alan Goh, Assistant Chief Executive, Platform Services at Synapxe (far left).

NUS-SYNAPXE-IMDA AI Innovation Challenge 2026

  1. Launched in January 2026, the Challenge culminated in March with eight finalist teams receiving two weeks of personalised mentorship from industry and public sector experts across multiple organisations to refine and strengthen their solutions.

  2. This year also marked a milestone for the Challenge, with Junior College students participating for the first time alongside universities and polytechnics. The expanded reach reflects the Challenge's growing role in nurturing a new generation of problem-solvers across Singapore's education landscape, bringing fresh perspectives to some of healthcare's most pressing challenges.

  3. To ensure that their solutions are both practical and relevant, students were encouraged to use the MERaLiON and SEA-LION Large Language Models (LLMs) (see Annex B (71.74KB) for details). These models, developed under the National Multimodal Large Language Model Programme (NMLP) supported by IMDA and the National Research Foundation (NRF), are designed to handle the complex language-switching communication styles and cultural nuances common in local settings. The models reflect Singapore’s and Southeast Asia’s diverse cultures, languages, and values.

  4. By understanding local languages and context, the models can enable AI‑powered healthcare solutions that are not only linguistically accurate but also empathetic and culturally sensitive. This supports the development of more personalised, inclusive, and accessible healthcare in Singapore.

  5. The MERaLiON and SEA-LION models were widely used by the students, including the top eight teams, to develop their solutions for this Challenge.

Four Student Teams Clinched Top Prizes with Innovative Healthcare Solutions

  1. Hosted at Synapxe’s Terrarium, the final round of presentations was evaluated by a distinguished panel of industry experts from the public, healthcare and academic sectors, who assessed the strategic and creative use of AI, as well as each prototype’s potential impact, feasibility and relevance to real-world healthcare needs.

  2. Team SilverGait from NUS and Team Med-SEAL from NUS received the second and third prizes of $7,000 and $5,000 respectively. SilverGait's multimodal, agentic AI system supports frailty detection, risk stratification, and personalised intervention for elderly adults in the community through continuous monitoring via computer vision and wearable data. Med-SEAL's AI-powered diagnostic support platform streamlines clinical workflows by automating preliminary reporting for clinicians while providing patients with clearer, culturally relevant explanations of their medical results, built on interoperable healthcare standards and multilingual capabilities within Southeast Asia.

  3. The NMLP Special Award and a cash prize of $5,000 was awarded to NUS’s Team Wait For A Name on the most effective and innovative use of the SEA-LION and MERaLiON large language models. Their solution, VitalSense, is a privacy-first, browser-based multimodal AI wellness assessment platform that enables users to complete a structured health screening in under five minutes using only a standard webcam, microphone, and self-reported vitals, without requiring a clinic visit.

Resources:

About Infocomm Media Development Authority

The Infocomm Media Development Authority (IMDA) leads Singapore’s digital transformation by developing a vibrant digital economy and an inclusive digital society. As Architects of Singapore’s Digital Future, we foster growth in Infocomm Technology and Media sectors in concert with progressive regulations, harnessing frontier technologies, and developing local talent and digital infrastructure ecosystems to establish Singapore as a digital metropolis.

For more news and information, visit www.imda.gov.sg or follow IMDA on LinkedIn (IMDAsg), Facebook (IMDAsg), and Instagram (@imdasg).

About National University of Singapore (NUS)

The National University of Singapore (NUS) is Singapore’s flagship university, which offers a global approach to education, research and entrepreneurship, with a focus on Asian perspectives and expertise. We have 15 colleges, faculties and schools across three campuses in Singapore, with more than 40,000 students from 100 countries enriching our vibrant and diverse campus community. We have also established more than 20 NUS Overseas Colleges entrepreneurial hubs around the world.

Our multidisciplinary and real-world approach to education, research and entrepreneurship enables us to work closely with industry, governments and academia to address crucial and complex issues relevant to Asia and the world. Researchers in our faculties, research centres of excellence, corporate labs and more than 30 university-level research institutes focus on themes that include energy; environmental and urban sustainability; treatment and prevention of diseases; active ageing; advanced materials; risk management and resilience of financial systems; Asian studies; and Smart Nation capabilities such as artificial intelligence, data science, operations research and cybersecurity.

For more information on NUS, please visit nus.edu.sg.

About NUS Business School

With 50,000 alumni and 60 global chapters, the National University of Singapore (NUS) Business School is known for providing management thought leadership from an Asian perspective, enabling its students and corporate partners to leverage global knowledge and Asian insights.

The school has consistently ranked first in Asia by independent publications and agencies, such as The Financial Times and Quacquarelli Symonds, in recognition of the quality of its programmes, faculty research and graduates.

The school is accredited by AACSB International (Association to Advance Collegiate Schools of Business) and EQUIS (European Quality Improvement System), endorsements that the school has met the highest standards for business education. The school is also a member of the Graduate Management Admission Council (GMAC), Executive MBA Council, Partnership in Management (PIM) and CEMS (Community of European Management Schools).

Established in 2013, the Business Analytics Centre (BAC) is a result of a collaborative effort between NUS and IBM. The Centre is the operational hub for the acclaimed NUS Master of Science in Business Analytics (MSBA) programme which seamlessly blends academic rigor with industrial expertise.

At NUS BAC, the MSBA programme draws on the strengths of both the NUS Business School and NUS Computing, ensuring a curriculum that integrates theoretical knowledge with real-world application. Over the past decade, BAC has built a strong network of over 100 industry partners.

To date, more than 1,000 industrial analytics and operations research projects have been completed by MSBA students in collaboration with leading corporations.

BAC is dedicated to developing future leaders in business analytics, empowering them to drive innovation and create impactful solutions across industries. For more information, visit https://msba.nus.edu.sg/.

About Synapxe

Synapxe is the national HealthTech agency inspiring tomorrow’s health. The nexus of HealthTech, we connect people and systems to power a healthier Singapore. Together with partners, we create intelligent technological solutions to improve the health of millions of people every day, everywhere. Reimagine the future of health together with us at www.synapxe.sg.

Frank Chua
Assistant Senior Manager
(Corporate Communications)
National University of Singapore, Business School
Email: frank.c@nus.edu.sg

Chan Ying Yen
Assistant Director
(Corporate Communications)
Synapxe
Email: chan.ying.yen@synapxe.sg

Priya Shandhini
Manager
(Communications and Marketing)
IMDA
Email: media@imda.gov.sg

Explore more

Related Programmes

10Gbps Nationwide Broadband Network (10G NBN) Grant Programme

10Gbps Nationwide Broadband Network (10G NBN) Grant

IMDA offers grants to support the development of Singapore's 10G Next-Generation Broadband Network, preparing the nation for...

GenAI Navigator Digital Solution

GenAI Navigator

A recommendation tool for SMEs, which provides recommendations based on SMEs’ specific business needs and guides them to...

Green DC Roadmap Programme

Green DC Roadmap

The Green DC Roadmap Fact Sheet details IMDA’s efforts in driving sustainable digital infrastructure through eco-friendly data...

View all programmes

About this source

GovPing monitors Singapore IMDA Press Releases for new telecom & technology regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 11 changes logged to date.

View all changes from Singapore IMDA Press Releases →

Get daily alerts for Singapore IMDA Press Releases

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from IMDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
IMDA
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Educational institutions Healthcare providers Technology companies
Industry sector
5112 Software & Technology
Activity scope
AI innovation competition Healthcare technology development
Geographic scope
Singapore SG

Taxonomy

Primary area
Artificial Intelligence
Operational domain
Compliance
Topics
Healthcare Data Privacy

Get alerts for this source

We'll email you when Singapore IMDA Press Releases publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!